Presentation THT 2024 Cardiac Recovery in Response to GDMT Presenter: Andreas Kalogeropoulos March 04, 2024
Presentation THT 2024 Myocardial Recovery at the Level of the Single Myocyte Presenter: Veli K. Topkara March 04, 2024
Presentation THT 2024 Current Understanding of the Incidence, Characteristics, and Sustainability of "Recoverers" in Response to LVAD Support Presenter: Emma Birks March 04, 2024
Presentation THT 2024 Contemporary Pharmacological Therapies for Acute Heart Failure Presenter: Wilfried Mullens March 04, 2024
Presentation THT 2024 Left-to-Right Shunting for Chronic Heart Failure: Overview of the Device Landscape Presenter: Benjamin Hibbert March 04, 2024
Presentation THT 2024 FDA-Approved But Less Frequently Used Device Therapies to Treat HFrEF: Challenges and Opportunities Presenter: Michael R. Zile March 04, 2024
News Daily News Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective Michael O'Riordan February 23, 2024
News Daily News New Risk Score Better for Capturing Medical Urgency for Heart Transplantation Michael O'Riordan February 19, 2024
News Daily News More Mortality Reduction Signals With Implantable Hemodynamic Monitors in HFrEF: Meta-analysis L.A. McKeown February 12, 2024
News Daily News CRT-D Offers Persistent Survival Benefit in Long-term RAFT Results Todd Neale January 23, 2024
News Daily News Experts Warn of Looming Private Equity Interest in Cardiology Care Michael O'Riordan January 15, 2024
News Daily News Most Takotsubo Patients Die From CV Causes, but Standard Meds No Help Todd Neale January 11, 2024